Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Ideaya Biosciences Inc (NASDAQ: IDYA) closed at $37.59 up 1.24% from its previous closing price of $37.13. In other words, the price has increased by $1.24 from its previous closing price. On the day, 0.78 million shares were traded. IDYA stock price reached its highest trading level at $38.5227 during the session, while it also had its lowest trading level at $36.85.
Ratios:
For a deeper understanding of Ideaya Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 19.65 and its Current Ratio is at 19.65. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on March 08, 2024, initiated with a Buy rating and assigned the stock a target price of $55.
On August 08, 2023, SVB Securities started tracking the stock assigning a Outperform rating and target price of $33.
On May 24, 2023, Goldman started tracking the stock assigning a Buy rating and target price of $32.Goldman initiated its Buy rating on May 24, 2023, with a $32 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 09 ’24 when Hata Yujiro S sold 23,557 shares for $45.54 per share. The transaction valued at 1,072,715 led to the insider holds 677,887 shares of the business.
Ruiz Briseno Andres sold 2,000 shares of IDYA for $92,045 on Feb 09 ’24. The insider now owns 24,531 shares after completing the transaction at $46.02 per share. On Feb 08 ’24, another insider, Hata Yujiro S, who serves as the President and CEO of the company, sold 75,815 shares for $45.15 each. As a result, the insider received 3,422,835 and left with 677,887 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IDYA now has a Market Capitalization of 2810401280 and an Enterprise Value of 2246180864. For the stock, the TTM Price-to-Sale (P/S) ratio is 119.83 while its Price-to-Book (P/B) ratio in mrq is 3.94. Its current Enterprise Value per Revenue stands at 96.052 whereas that against EBITDA is -17.023.
Stock Price History:
Over the past 52 weeks, IDYA has reached a high of $47.74, while it has fallen to a 52-week low of $14.33. The 50-Day Moving Average of the stock is -14.30%, while the 200-Day Moving Average is calculated to be 12.63%.
Shares Statistics:
For the past three months, IDYA has traded an average of 757.77K shares per day and 564340 over the past ten days. A total of 74.56M shares are outstanding, with a floating share count of 65.96M. Insiders hold about 11.54% of the company’s shares, while institutions hold 80.98% stake in the company. Shares short for IDYA as of 1711584000 were 9410615 with a Short Ratio of 12.42, compared to 1709164800 on 8558836. Therefore, it implies a Short% of Shares Outstanding of 9410615 and a Short% of Float of 12.740000000000002.
Earnings Estimates
Currently, IDNA analysts are dedicated to thoroughly evaluating and rating the performance of Ideaya Biosciences Inc (IDYA) in the stock market.The consensus estimate for the next quarter is $94.34, with high estimates of $25.22 and low estimates of $37.59.
